Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 72789-435

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 72789-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Wallet (833183d7 5be4 474a 8090 A1bba52c6341 01)

An instructional diagram depicting a weekly pill organizer for a 28-day regimen, with columns labeled Sunday through Saturday and rows labeled Week 1 through Week 4. Arrows guide the daily sequence to follow starting on Sunday, and there is a note advising placement of the day label strip if the period begins on a day other than Sunday. The right side includes a reminder for a monthly self-breast exam.*

FDA Label Image

Image (833183d7 5be4 474a 8090 A1bba52c6341 02)

A forest plot chart titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' showing effect estimates (odds ratios/relative risks) from various studies conducted between 2002 and 2017. The chart compares risk estimates for ever use and current use of combined oral contraceptives, with horizontal confidence intervals and point estimates displayed alongside study names and years on the vertical axis, and effect estimates on the horizontal axis ranging from -1.5 to 2.*

FDA Label Image

Image Structure (833183d7 5be4 474a 8090 A1bba52c6341 03)

Chemical structure diagrams of norgestimate and ethinyl estradiol, the active ingredients in the product. The left structure depicts norgestimate, while the right structure shows ethinyl estradiol, both shown with labeled chemical groups and bonds.*

FDA Label Image

Image (833183d7 5be4 474a 8090 A1bba52c6341 04)

FDA Label Image

Image Med Guide (833183d7 5be4 474a 8090 A1bba52c6341 05)

An illustration diagram showing a vertical arrow labeled from 'More Pregnancies' at the bottom to 'Fewer Pregnancies' at the top, with associated pregnancy rates per 100 women per year. To the right are boxes listing different birth control methods arranged from most to least effective: implants, injections, intrauterine devices, sterilization at the top; birth control pills, skin patch, vaginal ring with hormones below; condoms and diaphragm next; then behavioral methods and spermicides; and no birth control at the bottom.*

FDA Label Image

Image A-w Wallet (833183d7 5be4 474a 8090 A1bba52c6341 06)

An instructional diagram showing a four-week calendar layout for medication dosing, with days labeled Sunday through Saturday. It includes circles for each day in four rows labeled Week 1 to Week 4 and arrows indicating the order to take doses. The panel advises placement of a day label strip to start medication on any day other than Sunday and reminds monthly self breast exam.*

FDA Label Image

Image (833183d7 5be4 474a 8090 A1bba52c6341 07)

FDA Label Image

Wallet (833183d7 5be4 474a 8090 A1bba52c6341 08)

Packaging label for Tri-Lo-Marzia kit containing norgestimate and ethinyl estradiol tablets USP in strengths 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. The label includes storage instructions and manufacturer Lupin Limited India and distributor Lupin Pharmaceuticals, Inc. USA.*

FDA Label Image

Pouch (833183d7 5be4 474a 8090 A1bba52c6341 09)

Packaging label for Tri-Lo-Marzia, a kit containing norgestimate and ethinyl estradiol tablets USP. The label shows strengths of 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. It includes a blister pack of 28 tablets and is distributed by Lupin Pharmaceuticals, Inc. The label features usage warnings, dosage information, and a yellow-green gradient background with the Lupin logo.*

FDA Label Image

Image (72789435)

Label for a norgestimate and ethinyl estradiol kit containing 28 tablets. Each tablet has a strength of 0.180 mg/0.025 mg. The label includes the NDC number 72789-435-79 and is marked Rx only. Manufactured by PD-Rx Pharmaceuticals, Inc., located in Oklahoma City, OK. The label also provides reorder information, lot number LA00485, and expiration date of 01/2026.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.